- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- March 2024
- 30 Pages
Global
From €2641EUR$2,750USD£2,274GBP
- Report
- February 2023
- 220 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- April 2021
- 50 Pages
China
From €2497EUR$2,600USD£2,150GBP
- Report
- July 2018
- 30 Pages
China
From €2113EUR$2,200USD£1,819GBP
- Report
- July 2018
- 27 Pages
Global
From €9605EUR$10,000USD£8,269GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €21130EUR$22,000USD£18,192GBP
- Report
- January 2021
- 138 Pages
Global, China
From €3000EUR$3,346USD£2,673GBP
- Report
- June 2023
- 90 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- April 2023
- 111 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
Clopidogrel is a cardiovascular drug used to prevent blood clots in people with certain conditions, such as coronary artery disease, peripheral artery disease, and stroke. It works by blocking the action of certain natural substances that can cause blood clots. Clopidogrel is available in both generic and brand-name forms. It is usually taken once a day, with or without food.
Clopidogrel is a widely used drug in the cardiovascular market, with many generic and brand-name versions available. It is often prescribed in combination with other drugs, such as aspirin, to reduce the risk of stroke and heart attack. It is also used to prevent blood clots in people with certain conditions, such as atrial fibrillation.
Some companies in the clopidogrel market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin Pharmaceuticals, and Apotex. Show Less Read more